Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03848806 |
|
Recruitment Status :
Completed
First Posted : February 21, 2019
Last Update Posted : February 21, 2019
|
Sponsor:
Haus Bioceuticals
Information provided by (Responsible Party):
Haus Bioceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | July 11, 2016 |
| Actual Study Completion Date : | September 5, 2016 |